Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
New protein fragments identified for anthrax vaccine development

New protein fragments identified for anthrax vaccine development

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

Systematic method for improving the stability of antibodies

Systematic method for improving the stability of antibodies

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

Two senior members of Chertoff Group to provide operational advisory services to BioNeutral Group

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

Polymedix And UMass receive Phase I STTR contract for research on drug-resistant bacteria treatments

Enzymes could be targeted to kill dangerous pathogens

Enzymes could be targeted to kill dangerous pathogens

AVANIR raises funds to develop and commercialize Zenvia for PBA

AVANIR raises funds to develop and commercialize Zenvia for PBA

Free webinar for business travel industry on swine flu pandemic

Free webinar for business travel industry on swine flu pandemic

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

Universal Detection Technology signs new distribution agreement for bioterrorism technologies

Universal Detection Technology signs new distribution agreement for bioterrorism technologies

Human Genome Sciences achieves systemic lupus goals with candidate drug

Human Genome Sciences achieves systemic lupus goals with candidate drug

Pharmathene reports Q2 2009 financials

Pharmathene reports Q2 2009 financials

Response Biomedical announces Q2 2009 financials

Response Biomedical announces Q2 2009 financials

Automated network could predict disease outbreaks that originate in animals

Automated network could predict disease outbreaks that originate in animals

Aradigm receives orphan drug designation for inhaled liposomal ciprofloxacin to treat cystic fibrosis in Europe

Aradigm receives orphan drug designation for inhaled liposomal ciprofloxacin to treat cystic fibrosis in Europe

Delays could overwhelm hospitals in the event of airborne anthrax attack

Delays could overwhelm hospitals in the event of airborne anthrax attack

One secret to how tuberculosis resists the host immune system

One secret to how tuberculosis resists the host immune system

New discovery about mycobacteria – implications for tuberculosis research

New discovery about mycobacteria – implications for tuberculosis research

NanoBio starts clinical trial for adjuvanted intranasal flu vaccine

NanoBio starts clinical trial for adjuvanted intranasal flu vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.